CSS
BHVN

Cubist Systematic Strategies’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Cubist Systematic Strategies’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,740
Closed -$565K – 5001
2022
Q3 		$565K Sell
3,740
-1,414
-27% -$210K ﹤0.01% 3066
2022
Q2 		$751K Sell
5,154
-8,432
-62% -$1.08M ﹤0.01% 2710
2022
Q1 		$1.61M Buy
13,586
+8,941
+192% +$1.12M 0.01% 1671
2021
Q4 		$640K Buy
+4,645
New +$591K 0.01% 2267
2021
Q3 		– Sell
-9,727
Closed -$944K – 3353
2021
Q2 		$944K Buy
9,727
+6,613
+212% +$537K 0.01% 1613
2021
Q1 		$213K Sell
3,114
-46,483
-94% -$3.76M ﹤0.01% 2432
2020
Q4 		$4.25M Buy
49,597
+38,284
+338% +$3.24M 0.06% 520
2020
Q3 		$735K Buy
11,313
+7,940
+235% +$520K 0.01% 1510
2020
Q2 		$247K Buy
+3,373
New +$180K ﹤0.01% 1942
2020
Q1 		– Sell
-22,800
Closed -$1.24M – 2674
2019
Q4 		$1.24M Buy
+22,800
New +$1.13M 0.02% 1025
2019
Q3 		– Sell
-6,884
Closed -$301K – 2693
2019
Q2 		$301K Buy
6,884
+5,657
+461% +$319K 0.01% 1800
2019
Q1 		$63K Sell
1,227
-22,862
-95% -$988K ﹤0.01% 2068
2018
Q4 		$891K Buy
24,089
+4,750
+25% +$171K 0.04% 621
2018
Q3 		$726K Buy
19,339
+10,376
+116% +$382K 0.04% 616
2018
Q2 		$354K Buy
+8,963
New +$284K 0.02% 979
2018
Q1 		– Sell
-12,492
Closed -$337K – 2260
2017
Q4 		$337K Buy
+12,492
New +$344K 0.02% 1171
2017
Q3 		– Sell
-8,592
Closed -$215K – 2172
2017
Q2 		$215K Buy
+8,592
New +$198K 0.01% 1248

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Cubist Systematic Strategies's BHVN Position: Q4 2022 in Review

Cubist Systematic Strategies sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 3,740 shares — an estimated $565K sold.

Cubist Systematic Strategies first reported a position in BHVN in Q2 2017 and held it in 17 quarters. The position peaked at $4.25M in Q4 2020. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Cubist Systematic Strategies reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 3,740 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $565K.
  • Cubist Systematic Strategies first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 17 quarters.
  • Cubist Systematic Strategies's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4.25M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.